Soleno Therapeutics Inc (SLNO)
EBITDA Margin
38.81%
Quarterly · Period ending:
SLNO EBITDA Margin
Latest reported38.81%period ending
Latest reported38.81%period ending
SLNO Quarterly EBITDA Margin (65.65% → 38.81%)
Quarterly ebitda margin
High-resolution chart · PNG
SLNO ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 38.8138% | |
| 49.2925% | |
| 42.2688% | |
| -8.6658% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -0.2891% | |
| 0% | |
| -251,700% | |
| -473.2075% | |
| -900.0944% | |
| -586.3222% | |
| -580.5627% | |
| -949.217% | |
| -1,431.3585% | |
| -3,508.6957% | |
| -9,462.5% | |
| -10,959.0909% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 65.6507% |